Business, energy, technology, markets and global industry news from Business News Today

South Korea

PharmaDeviceNews South Korea
Galderma expands Alastin professional skincare across Japan and key Asia Pacific medical aesthetics markets as demand for procedure-linked skincare grows. Representative image.
Pharma & Biotech

Galderma is taking Alastin deeper into Asia, but this launch is about more than skincare

Galderma expands Alastin across Japan and Asia Pacific, linking premium skincare with rising demand for aesthetic procedures.

Read More
Neuronata-R’s continued conditional approval in South Korea shifts attention to CorestemChemon’s planned ALS stem cell therapy manufacturing restart in 2027. Representative image.
Pharma & Biotech

South Korea kept Neuronata-R on the market. Now CorestemChemon’s harder test begins

South Korea keeps Neuronata-R available after Phase 3 review, but manufacturing, patient selection and a delayed U.S. filing remain decisive tests ahead.

Read More
Arialys Therapeutics’ ART5803 has received FDA Fast Track designation as the company advances a Phase 2 precision therapy for anti-NMDA receptor encephalitis. Representative image.
Pharma & Biotech

ART5803 gets FDA Fast Track status, but the real test for Arialys Therapeutics begins in Phase 2

FDA Fast Track status advances Arialys Therapeutics’ ART5803 as Phase 2 trials test a precision approach to anti-NMDA receptor encephalitis.

Read More